Scancell【SCLP】銘柄情報

Scancell Hldgs Plc (SCLP) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

18.75

( -8.54% )

買値

18.50

売値

19.00

出来高

3,390,363

18.25 日の範囲 20.50

7.90 52 週間の範囲 29.50

時価総額

194.584M

前日終値

20.50

始値

20.50

時刻

50000

18.92

(O)

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

2,070,261p

発行済株式数

1,037,781,403

配当利回り

PER

-31.65

1 株当たり利益 (EPS)

-0.01

歳入

4.71M

純利益

-5.51M

Scancell Holdings plc, a clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom. Its product candidates include SCIB1/iSCIB1+ that is in Phase II for the treatment of melanoma; and SC134, an antibody for the treatment of ... Scancell Holdings plc, a clinical stage biopharmaceutical company, discovers and develops of immunotherapies for the treatment of cancer in the United Kingdom. Its product candidates include SCIB1/iSCIB1+ that is in Phase II for the treatment of melanoma; and SC134, an antibody for the treatment of small cell lung cancer. It also develops Modi-1, an active peptide immunotherapy that is in phase II clinical trials for the treatment of solid tumors, including renal, head and neck, ovarian and triple negative breast cancers; and Modi-2, which targets stress-induced post translational modifications, such as homocittrullination. In addition, the company provides GlyMab platform that generates various affinity tumour specific monoclonal antibodies (mAb) targeting glycans that are over-expressed on cancer cells; and AvidiMab, which romotes receptor clustering thereby improving immune signalling. Scancell Holdings plc was founded in 1996 and is based in Oxford, the United Kingdom. 詳細を表示

セクター

Healthcare

業界

Biotechnology & Life Sciences

ウェブサイト

www.scancell.co.uk

本社

Oxford, United Kingdom

設立

1996

Scancell Hldgs Plc is listed in the Healthcare sector of the ロンドン証券取引所 with ticker SCLP. The last closing price for Scancell was 20.50p. Over the last year, Scancell shares have traded in a share price range of 7.90p to 29.50p.

Scancell currently has 1,037,781,403 shares in issue. The market capitalisation of Scancell is £194.58 million. Scancell has a price to earnings ratio (PE ratio) of -31.65.

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-4.25	-18.4782608696	23	23	18.25	1273674	21.49617806	DE
4	-1.5	-7.40740740741	20.25	29.5	18.25	3329780	23.08669782	DE
12	6.5	53.0612244898	12.25	29.5	11	2174287	18.75363795	DE
26	8.85	89.3939393939	9.9	29.5	9.75	1779080	15.91616832	DE
52	8.25	78.5714285714	10.5	29.5	7.9	1349631	13.73039913	DE
156	4.275	29.5336787565	14.475	29.5	7.25	957201	12.8511511	DE
260	-3.75	-16.6666666667	22.5	29.5	7.25	917627	14.90553183	DE